Drug Type asPNA |
Synonyms- |
Target |
Mechanism FtsZ inhibitors(bacterial FtsZ inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
MRSA - Methicillin resistant Staphylococcus aureus infection | Preclinical | CN | 01 Feb 2015 | |
Staphylococcal Infections | Preclinical | CN | 01 Feb 2015 |